Clinical trials
Central Nervous System Diseases trials in Spain
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
38 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2007 | 1 |
| 2009 | 1 |
| 2010 | 3 |
| 2011 | 1 |
| 2012 | 2 |
| 2014 | 1 |
| 2016 | 2 |
| 2017 | 2 |
| 2018 | 3 |
| 2019 | 1 |
| 2020 | 2 |
| 2021 | 3 |
| 2022 | 5 |
| 2023 | 6 |
| 2024 | 2 |
| 2025 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 16 |
| Terminated | 8 |
| Active, not recruiting | 6 |
| Recruiting | 4 |
| Withdrawn | 2 |
| No longer available | 1 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AbbVie | 4 |
| AstraZeneca | 3 |
| Connecta Therapeutics, S.L. | 3 |
| Bial R&D Investments, S.A. | 2 |
| Eli Lilly and Company | 2 |
| GlaxoSmithKline | 2 |
| Novartis Pharmaceuticals | 2 |
| AC Immune SA | 1 |
| Amzell | 1 |
| Avraham Pharmaceuticals Ltd | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Central Nervous System Diseases | 38 |
| Brain Diseases | 27 |
| Nervous System Diseases | 22 |
| Neurodegenerative Diseases | 15 |
| Alzheimer Disease | 13 |
| Dementia | 12 |
| Mental Disorders | 12 |
| Movement Disorders | 8 |
| Neurocognitive Disorders | 7 |
| Tauopathies | 7 |
Trials
Showing 51 to 38 of 38. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.